Neuropatía diabética y hemoglobina glicosilada > 6.5% en mayores de 40 años

Introduction: The most common complication of type 2 diabetes mellitus is neuropathy, one of the main causes of lower limb amputation. Glycosylated hemoglobin as a predictor of microvascular damage causes nervous-sensory alterations. Objective: To establish the relationship between diabetic neuropathy and HbA1c >6.5% in patients with T2D aged 40 to 65 years in the Family Medicine Unit No. 9. Methods: A cross-sectional, correlational study included patients with T2DM aged 40 to 65 years, with HbA1C levels > 6.5%, without a diagnosis of neuropathy. The Michigan Neuropathy Screening Instrument (MNSI) was used, divided into 2 parts, self-assessment questionnaire and physical examination, involving 220 patients. Results: A total of 220 patients, women (57.7%) and a range of 46 to 50 years (27.3%). 51.4% did not have neuropathy versus 28.1% with neuropathic symptoms. The prevalence of neuropathy increased with age (10%) and the time of evolution of diabetes: 10.2% with diabetes from 5 to 10 years, 80.6% in those over 20 years of age. The significance between the variables was p<0.0001. Conclusions: Neuropathy is related to elevated HbA1c levels >6.5%, which suggests a very strong correlation with the H1 hypothesis.